Pfizer in November released initial trial results on the vaccine that is currently under review by health regulators in both the United States Europe. The U.S. Food and Drug Administration is expected to decide on its use by August. New Delhi: Pfizer Inc’s experimental respiratory […]
The injection known as Gohibic targets a part of the immune system that is thought to play a role in the inflammation that leads to COVID-19 disease progression. New Delhi: The U.S. Food and Drug Administration (FDA) on Tuesday granted emergency-use authorization to Inflarx NV’s […]
The NPPA, in a gazette notification on March 31, said that the ceiling price of the medicine is arrived at after considering the Wholesale Price Index of 12.12 per cent for the year 2022 over 2021. In the 103-page notification it has given a list […]
The leading vaccine maker is working with Bank of America on the demerger process, said the people cited above. About 60% of Sanofi India is owned by Sanofi and wholly owned subsidiary Hoechst Gmbh. The rest is held by foreign and domestic institutional investors along […]
The Dublin, Ohio-based drug distributor has been in talks with advisers to examine interest in the unit, which makes radioactive agents and drugs that doctors use to diagnose and treat diseases such as cancer, the report said. Cardinal Health Inc is exploring a potential sale […]
A ransomware group has claimed responsibility for an ‘IT security incident’ at Sun Pharma whose effect included breach of certain file systems and the theft of certain company data and personal data, the drugmaker said in a stock exchange filing. Pharmaceutical industries is set to […]
The company had filed a patent for Fumarate salt of bedaquiline in 2008 to extend its patent till the end of 2027. It was under review by the patent office. The strategy is called patent evergreening used by companies to keep the prices high as […]
March-in rights, which have never been used before, allow the government to grant additional licenses to third parties for products developed using federal funds if the original patent holder does not make them available to the public on reasonable terms. U.S. government will not force […]
“The committee recommends that specific targets, both short term and long term, should be set for reducing the dependence on imported raw materials from around 80 per cent at present to 30 or 40 per cent in the next five years,” says the panel headed […]
TPG’s likely stake sale is seen attracting global PE funds which have already struck several deals in India’s pharma and healthcare sector Private equity investor TPG Capital is looking to exit its five-year-old investment in Hyderabad-based Sai Life Sciences, a pharmaceutical contract development and manufacturing […]